Ebumab Holding ApS (CVR 39807556)
|
14.01.2023
| 14.02.2023 |
10,00-14,99%
|
10,00 %
|
RA Capital Healthcare Fund, L.P. |
20.12.2022
| 14.02.2023 |
20,00-24,99%
|
20,00 %
|
Ebumab Holding ApS (CVR 39807556)
|
20.12.2022
| 13.01.2023 |
15,00-19,99%
|
15,00 %
|
Novo Holdings A/S (CVR 24257630)
|
04.05.2022
| 14.02.2023 |
25,00-33,32%
|
25,00 %
|
RA Capital Healthcare Fund, L.P. |
04.05.2022
| 19.12.2022 |
15,00-19,99%
|
15,00 %
|
Ebumab Holding ApS (CVR 39807556)
|
04.05.2022
| 19.12.2022 |
20,00-24,99%
|
20,00 %
|
RA Capital Nexus Fund II, L.P. |
22.07.2021
| 14.02.2023 |
5,00-9,99%
|
5,00 %
|
RA Capital Healthcare Fund, L.P. |
22.07.2021
| 03.05.2022 |
10,00-14,99%
|
10,00 %
|
Ebumab Holding ApS (CVR 39807556)
|
22.07.2021
| 03.05.2022 |
25,00-33,32%
|
25,00 %
|
Novo Holdings A/S (CVR 24257630)
|
22.07.2021
| 03.05.2022 |
33,33-49,99%
|
33,33 %
|
Novo Holdings A/S (CVR 24257630)
|
20.11.2020
| 21.07.2021 |
33,33-49,99%
|
33,33 %
|
Ebumab Holding ApS (CVR 39807556)
|
20.11.2020
| 21.07.2021 |
50,00-66,66%
|
50,00 %
|
GV1 Holding ApS (CVR 41370351)
|
22.06.2020
| 20.11.2020 |
5,00-9,99%
|
5,00 %
|
Ebumab Holding ApS (CVR 39807556)
|
22.06.2020
| 19.11.2020 |
90,00-99,99%
|
90,00 %
|
Ebumab Holding ApS (CVR 39807556)
|
27.09.2019
| 21.06.2020 |
100,00%
|
100,00 %
|